参考文献
① Cherbuin, N., Sachdev, P., & Anstey, K. J. (2012). Higher normal fasting plasma glucose is associated with hippocampal atrophy: The PATH Study. Neurology, 79(10), 1019–1026. https://doi.org/10.1212/WNL.0b013e31826846de
② Watt, C., Sanchez-Rangel, E., & Hwang, J. J. (2020). Glycemic variability and CNS inflammation: Reviewing the connection. Nutrients, 12(12), 3906. https://doi.org/10.3390/nu12123906
③ Zhang, S., et al. (2023). Glycemic variability correlates with medial temporal lobe atrophy and decreased cognitive performance in patients with memory deficits. (2023). Frontiers in Aging Neuroscience, 15, 1156908. https://doi.org/10.3389/fnagi.2023.1156908
④ Chi, H., et al. (2024). Glucose fluctuation inhibits Nrf2 signaling pathway in hippocampal tissues and exacerbates cognitive impairment in streptozotocin-induced diabetic rats. Journal of Diabetes Research, 2024, 5584761. https://doi.org/10.1155/2024/5584761
⑤ de la Monte, S. M., & Wands, J. R. (2008). Alzheimer’s disease is type 3 diabetes—Evidence reviewed. Journal of Diabetes Science and Technology, 2(6), 1101–1113. https://doi.org/10.1177/193229680800200619
⑥ Atabi, F., et al. (2025). A systematic review on type 3 diabetes: bridging the gap between metabolic dysfunction and Alzheimer’s disease. Diabetology & Metabolic Syndrome, 17, 356. https://doi.org/10.1186/s13098-025-01930-2
① Cherbuin, N., Sachdev, P., & Anstey, K. J. (2012). Higher normal fasting plasma glucose is associated with hippocampal atrophy: The PATH Study. Neurology, 79(10), 1019–1026. https://doi.org/10.1212/WNL.0b013e31826846de
② Watt, C., Sanchez-Rangel, E., & Hwang, J. J. (2020). Glycemic variability and CNS inflammation: Reviewing the connection. Nutrients, 12(12), 3906. https://doi.org/10.3390/nu12123906
③ Zhang, S., et al. (2023). Glycemic variability correlates with medial temporal lobe atrophy and decreased cognitive performance in patients with memory deficits. (2023). Frontiers in Aging Neuroscience, 15, 1156908. https://doi.org/10.3389/fnagi.2023.1156908
④ Chi, H., et al. (2024). Glucose fluctuation inhibits Nrf2 signaling pathway in hippocampal tissues and exacerbates cognitive impairment in streptozotocin-induced diabetic rats. Journal of Diabetes Research, 2024, 5584761. https://doi.org/10.1155/2024/5584761
⑤ de la Monte, S. M., & Wands, J. R. (2008). Alzheimer’s disease is type 3 diabetes—Evidence reviewed. Journal of Diabetes Science and Technology, 2(6), 1101–1113. https://doi.org/10.1177/193229680800200619
⑥ Atabi, F., et al. (2025). A systematic review on type 3 diabetes: bridging the gap between metabolic dysfunction and Alzheimer’s disease. Diabetology & Metabolic Syndrome, 17, 356. https://doi.org/10.1186/s13098-025-01930-2